JP Morgan Chase’s IceCure Medical ICCM Stock Holding History

JP Morgan Chase’s Portfolio ICCM Stock Details ICCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.67K	Hold	198	–	–	﹤0.01%	7049
2025 Q4	$3.63K	Hold	198	–	–	﹤0.01%	6861
2025 Q3	$6.07K	Hold	198	–	–	﹤0.01%	6740
2025 Q2	$5.92K	Hold	198	–	–	﹤0.01%	6401
2025 Q1	$7.08K	Hold	198	–	–	﹤0.01%	6374
2024 Q4	$6.54K	Hold	198	–	–	﹤0.01%	6466
2024 Q3	$3.63K	Hold	198	–	–	﹤0.01%	6546
2024 Q2	$4.4K	Hold	198	–	–	﹤0.01%	6408
2024 Q1	$7.14K	Hold	198	–	–	﹤0.01%	6390
2023 Q4	$6.37K	Hold	198	–	–	﹤0.01%	6510
2023 Q3	$3.3K	Buy	+198	New	+$6.23K	﹤0.01%	6451
2023 Q2	–	Sell	-15	Closed	-$1K	–	7099
2023 Q1	$1K	Sell	15 -315	-95%	-$11.7K	﹤0.01%	6521
2022 Q4	$15K	Buy	+330	New	+$11.8K	﹤0.01%	5959
2022 Q3	–	Sell	-241	Closed	-$78K	–	6635
2022 Q2	$78K	Buy	+241	New	+$14.5K	﹤0.01%	5519
2022 Q1	–	Sell	-2,697	Closed	-$247K	–	6786
2021 Q4	$247K	Buy	+2,697	New	+$451K	﹤0.01%	5230

Other funds holding ICCM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CIA

Concurrent Investment Advisors Tampa, Florida $11.8B AUM 31.86% 1-Year Est. Return

WAM

Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return

GCM

Gunderson Capital Management Mt. Pleasant, South Carolina $370M AUM 211.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

KFG

Kingdom Financial Group Peoria, Arizona $349M AUM 12.25% 1-Year Est. Return

JP Morgan Chase's ICCM Position: Q1 2026 in Review

JP Morgan Chase held its IceCure Medical (ICCM) position steady in Q1 2026 at 198 shares worth $1.67K. The position accounts for ﹤0.01% of the portfolio, ranked #7049.

JP Morgan Chase first reported a position in ICCM in Q4 2021 and has held it in 15 quarters since. The position peaked at $247K in Q4 2021. 17 funds tracked by Wall St. Rank hold ICCM as of Q1 2026.

JP Morgan Chase held 198 shares of IceCure Medical worth $1.67K as of Q1 2026.
JP Morgan Chase left its IceCure Medical share count unchanged in Q1 2026.
IceCure Medical made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7049 holding.
JP Morgan Chase first reported a position in IceCure Medical in Q4 2021 and has held it in 15 quarters since.
JP Morgan Chase's IceCure Medical position peaked at $247K in Q4 2021.
17 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.